Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Sean N. Tucker"'
Autor:
Molly R. Braun, Anne C. Moore, Jonathan D. Lindbloom, Katherine A. Hodgson, Emery G. Dora, Sean N. Tucker
Publikováno v:
Vaccines, Vol 12, Iss 9, p 955 (2024)
Therapeutic vaccination can harness the body’s cellular immune system to target and destroy cancerous cells. Several treatment options are available to eliminate pre-cancerous and cancerous lesions caused by human papillomaviruses (HPV), but may no
Externí odkaz:
https://doaj.org/article/13084199717a41a68551113613ad3ced
Autor:
Philip J. Kuehl, Justin Dearing, Adam Werts, Jason Cox, Hammad Irshad, Edward G. Barrett, Sean N. Tucker, Stephanie N. Langel
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible respiratory pathogen whose main transmission route is respiratory droplets and/or aerosols. The development of an animal model and exposure system that re
Externí odkaz:
https://doaj.org/article/0b5b259c5d114407b5e0bd8fe921f929
Autor:
Sarah N. Tedjakusuma, Colin A. Lester, Elena D. Neuhaus, Emery G. Dora, Samanta Gutierrez, Molly R. Braun, Sean N. Tucker, Becca A. Flitter
Publikováno v:
Vaccines, Vol 12, Iss 2, p 132 (2024)
As new SARS-CoV-2 variants continue to emerge and impact communities worldwide, next-generation vaccines that enhance protective mucosal immunity may have a significant impact on productive infection and transmission. We have developed recombinant no
Externí odkaz:
https://doaj.org/article/ecac1522101542b4941be4df1178c00a
Autor:
Molly R. Braun, Clarissa I. Martinez, Emery G. Dora, Laura J. Showalter, Annette R. Mercedes, Sean N. Tucker
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
SARS-CoV-2 variant clades continue to circumvent antibody responses elicited by vaccination or infection. Current parenteral vaccination strategies reduce illness and hospitalization, yet do not significantly protect against infection by the more rec
Externí odkaz:
https://doaj.org/article/582c61b3445c4c029cc2944d425903bc
Publikováno v:
Vaccines, Vol 10, Iss 4, p 593 (2022)
To effectively combat emerging infections and prevent future pandemics, next generation vaccines must be developed quickly, manufactured rapidly, and most critically, administered easily. Next generation vaccines need innovative approaches that preve
Externí odkaz:
https://doaj.org/article/8689341aae7f4ff28e554952e4950ed5
Autor:
Sarah N Tedjakusuma, Clarissa I Martinez, Adam Werts, Adriana E. Kajon, Emery G. Dora, Sean N. Tucker, Susan A. Johnson, Sharla M Birch, Nadine Peinovich
Publikováno v:
The Journal of Infectious Diseases
Background Vaccines that are shelf stable and easy to administer are crucial to improve vaccine access and reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission around the world. Methods In this study, we demonstrate that a
Autor:
Sarah N. Tedjakusuma, Colin A. Lester, Elena D. Neuhaus, Emery G. Dora, Sean N. Tucker, Becca A. Flitter
As new SARS-CoV-2 variants continue to emerge and impact communities worldwide, efforts to develop next generation vaccines that enhance mucosal immunity would be beneficial for protecting individuals and reducing community transmission. We have deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed8a10d0d2c0b043870b9c6528b351c1
https://doi.org/10.1101/2022.12.19.521127
https://doi.org/10.1101/2022.12.19.521127
Autor:
Becca A Flitter, Sarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, Susan Johnson, Emery G Dora, Nadine Peinovich, Clara B Jegede, Sean N Tucker
Publikováno v:
Open Forum Infectious Diseases. 9
Background Mucosal vaccination may offer increased protection against SARS-CoV-2 compared to parental immunization. Here, we describe immunogenicity and efficacy following viral challenge in non-human primates after intranasal delivery of three uniqu
Autor:
Philip J. Kuehl, Justin Dearing, Adam Werts, Jason Cox, Hammad Irshad, Edward G. Barrett, Sean N. Tucker, Stephanie N. Langel
SARS-CoV-2 is a highly transmissible respiratory pathogen whose main transmission route is airborne. Development of an animal model and exposure system that recapitulates airborne transmission of SARS-CoV-2 is integral for understanding the dynamics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2d41d1966f1233ce332a788d9583f8a
https://doi.org/10.1101/2022.11.18.517035
https://doi.org/10.1101/2022.11.18.517035
Autor:
Stephanie N. Langel, Susan Johnson, Clarissa I. Martinez, Sarah N. Tedjakusuma, Nadine Peinovich, Emery G. Dora, Philip J. Kuehl, Hammad Irshad, Edward G. Barrett, Adam D. Werts, Sean N. Tucker
Publikováno v:
Science translational medicine. 14(658)
Transmission-blocking strategies that slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect against coronavirus disease 2019 (COVID-19) are needed. We have developed an orally delivered adenovirus type 5–vector